Disease Progression: Various factors that influence HCV disease progression including steatosis, obesity, insulin resistance, diabetes, race/ethnicity, and general studies on disease progression.



o       1330. Effects of chronic HCV infection on health-related quality of life and fatigue: the role of liver fibrosis progression (updated November 6, 2007)

o       1336. Tracking the Course of Hepatitis C with Paired Biopsies - A Critical Analysis (updated November 6, 2007)

o       1337. Long-term Morbidity and Mortality of HCV Infection: A 25 years Follow-up

o       1340. Histological Outcomes After 30 Years In Untreated Irish Women With Chronic HCV Genotype 1b, Do Genetic Factors Influence? (updated November 6, 2007)

o       1341. Higher Caffeine Consumption is associated with Milder Fibrosis in patients with Chronic Liver Diseases

o       1347. Obesity is an Independent predictor of fibrosis progression in patients with chronic Hepatitis C Virus (HCV) using paired liver biopsy specimens (updated November 6, 2007)

o       1360. Cause of Death in Patients with Hepatitis C (HCV)-Mixed Cryoglobulinemia (MC) Vasculitis

o       1366. Host rather than viral factors reduce health-related quality of life in hepatitis C virus infection (updated November 19, 2007)


        Hepatocellular Carcinoma

o       133. Chronic hepatitis C virus infection and risk of hepatocellular carcinoma: a community-based prospective study on 19,565 residents in Taiwan


        Metabolic disorders

o       533. High Prevalence of Glomerulonephritis in Patients with End-stage HCV-induced Cirrhosis



o       354. The Role of Steatosis and Diabetes as a Predictor of Treatment Response to Interferon Based Therapies in Latino Americans with Chronic Hepatitis C



o       301. The Impact Of Steatosis And Steatohepatitis On The Response To Treatment In Patients With Chronic Hepatitis C Infection